Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

385

HTML

4606

Tables (1-17)

318

Sum=5309

May 21, 2005 (publication date) through Mar 3, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. May 21, 2005; 11(19): 2892-2899
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2892

Table 15 Efficacy in ALT activity between two groups before and after treatment.

In comparison of efficacy between two groups, central effect-oriented CMH method was employed. Q of statistics was Q_CMH.

Citation: Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol 2005; 11(19): 2892-2899
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2892.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2892